Cargando…

Patient-Reported Outcomes After Chemoradiation in Patients With Anal Cancer: A Qualitative Analysis

PURPOSE: Pelvic chemoradiation therapy (CRT) is the curative therapy for non-metastatic anal cancer, resulting in excellent survival rates. However, anal cancer survivors may experience diminished quality of life (QOL) due to late toxicities from pelvic CRT. Few studies use patient-reported QOL, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corrigan, Kelsey L., De, Brian, Rooney, Michael K., Ludmir, Ethan B., Das, Prajnan, Smith, Grace L., Taniguchi, Cullen M., Minsky, Bruce D., Koay, Eugene J., Koong, Albert C., Holliday, Emma B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157211/ https://www.ncbi.nlm.nih.gov/pubmed/35662810 http://dx.doi.org/10.1016/j.adro.2022.100986

Ejemplares similares

Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution
por: Holliday, Emma B, et al.
Publicado: (2022)

Differential Spatial Gene and Protein Expression Associated with Recurrence Following Chemoradiation for Localized Anal Squamous Cell Cancer
por: Hernandez, Sharia, et al.
Publicado: (2023)

Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer
por: Moningi, Shalini, et al.
Publicado: (2022)

Definitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignancies
por: Moningi, Shalini, et al.
Publicado: (2019)

IMRT Reduces Acute Toxicity in Patients Treated With Preoperative Chemoradiation for Gastric Cancer
por: Moningi, Shalini, et al.
Publicado: (2019)

Anal cancer treatment regimen considerations for the COVID-19 era: In regard to Tchelebi et al
por: Noticewala, Sonal S., et al.
Publicado: (2020)

Hyperfractionated abdominal reirradiation for gastrointestinal malignancies
por: Hunt, Andrew, et al.
Publicado: (2018)

Assessment of setup uncertainty in hypofractionated liver radiation therapy with a breath-hold technique using automatic image registration–based image guidance
por: Choi, Gye Won, et al.
Publicado: (2019)

Mass Transport Model of Radiation Response: Calibration and Application to Chemoradiation for Pancreatic Cancer
por: Wang, Charles X., et al.
Publicado: (2022)

Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma
por: De, Brian, et al.
Publicado: (2021)

Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era
por: Abi Jaoude, Joseph, et al.
Publicado: (2021)

NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience
por: Bagley, Alexander F., et al.
Publicado: (2022)

Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis
por: Dodoo, Grace N, et al.
Publicado: (2023)

CEA as a blood-based biomarker in anal cancer
por: Hester, Robert, et al.
Publicado: (2021)

Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Metastases
por: De, Brian, et al.
Publicado: (2023)

Outcomes and Toxicities of Modern Combined Modality Therapy with Atezolizumab Plus Bevacizumab and Radiation Therapy for Hepatocellular Carcinoma
por: Manzar, Gohar Shahwar, et al.
Publicado: (2022)

Endoscopic Ultrasound-Guided Fiducial Placement for Stereotactic Body Radiation Therapy in Patients with Pancreatic Cancer
por: Cazacu, Irina M., et al.
Publicado: (2023)

Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic Cancer
por: Moningi, Shalini, et al.
Publicado: (2020)

Dose escalation for locally advanced pancreatic cancer: How high can we go?
por: Colbert, Lauren E., et al.
Publicado: (2018)

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma
por: Elganainy, Dalia, et al.
Publicado: (2018)

Dose Escalation for Pancreas SBRT: Potential and Limitations of using Daily Online Adaptive Radiation Therapy and an Iterative Isotoxicity Automated Planning Approach
por: Rhee, Dong Joo, et al.
Publicado: (2023)

Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy
por: De, Brian, et al.
Publicado: (2021)

Impact factor and citation metrics in phase III cancer trials
por: Abi Jaoude, Joseph, et al.
Publicado: (2021)

Long-Term Outcomes of Chemoradiation for Anal Cancer Patients
por: Kim, Hun Jin, et al.
Publicado: (2013)

Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus
por: Holliday, Emma B., et al.
Publicado: (2017)

Linguistic Biases in Letters of Recommendation for Radiation Oncology Residency Applicants from 2015 to 2019
por: Chapman, Bhavana V., et al.
Publicado: (2020)

Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiation
por: Jensen, Garrett, et al.
Publicado: (2018)

HPV-related anal cancer is associated with changes in the anorectal microbiome during cancer development
por: Elnaggar, Jacob H., et al.
Publicado: (2023)

Implementation of a stereotactic body radiotherapy program for unresectable pancreatic cancer in an integrated community academic radiation oncology satellite network
por: Augustyn, Alexander, et al.
Publicado: (2021)

Combined modality chemoradiation in elderly oesophageal cancer patients
por: Anderson, S E, et al.
Publicado: (2007)

Efficacy and toxicity of chemoradiation in patients with anal cancer - a retrospective analysis
por: Koerber, Stefan Alexander, et al.
Publicado: (2014)

Penile Mondor's disease in a patient treated with radical chemoradiation for anal cancer
por: Pittaka, Maria, et al.
Publicado: (2017)

Racial disparities in receipt of standard chemoradiation in anal squamous cell carcinoma, an analysis of the National Cancer Database
por: Bian, Shelly X., et al.
Publicado: (2020)

A multi-disciplinary model of survivorship care following definitive chemoradiation for anal cancer
por: Savoie, Marissa B., et al.
Publicado: (2019)

Trends in Publication Speed of Radiation Oncology Research from 2010 to 2019
por: Rooney, Michael K., et al.
Publicado: (2021)

Patient-Reported Outcome Measures in Pancreatic Cancer Receiving Radiotherapy
por: Kouzy, Ramez, et al.
Publicado: (2020)

Brachytherapy boost after chemoradiation in anal cancer: a systematic review
por: Frakulli, Rezarta, et al.
Publicado: (2018)

Cancer Research after COVID-19: Where Do We Go from Here?
por: Colbert, Lauren E., et al.
Publicado: (2020)

Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials
por: Lin, Timothy A., et al.
Publicado: (2020)

Professional Medical Writer Assistance in Oncology Clinical Trials
por: Kouzy, Ramez, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_psa8kjm5p39ouffugaveavnvdk